National Cancer Registry Ireland
Essential information on cancer in Ireland
Increase
Decrease
Normal
Current Size:
100%
Search
Home
About us
News
Contact us
General overview
Governance
Vacancies
Our staff
Links
Video gallery
Customer charter
Data & statistics
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival Statistics
Incidence rates mapped
Data request
Publications
Annual financial reports
Strategic plans
Cancer trends & projections
Statistical reports
Cancer atlases
Research publications
Research reports
Scientific papers
Presentations
All Ireland cancer statistics
Infographics
Research
Research projects
Research publications
Research reports
Scientific papers
Presentations
FAQs
All FAQs
FAQs about us
About our data & how we collect it
Using & interpreting our data
Cancer information
Troubleshooting
8C: Treatment - radiotherapy
Home
/
Data & statistics
/
Performance indicators
/
8C: Treatment - radiotherapy
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival Statistics
Incidence rates mapped
Data request
Request specific grouped data
% of Cases treated with Radiotherapy
UKIACR average (population)
UKIACR average (country)
England
Scotland
Wales
Northern Ireland
Republic of Ireland
All invasive xnmsc
19.5%
18.7%
20.0%
20.1%
10.9%
25.5%
17.0%
All xnmsc 0-24
12.9%
12.1%
13.5%
10.0%
7.3%
20.3%
9.1%
All xnmsc 25-59
22.2%
21.7%
22.6%
24.0%
13.4%
29.8%
18.9%
All xnmsc 60-79
21.8%
20.5%
22.5%
22.1%
12.0%
28.0%
18.0%
All xnmsc 80+
11.4%
10.6%
11.8%
10.7%
6.2%
13.5%
10.9%
Haematology
8.7%
8.0%
9.1%
8.2%
3.6%
11.7%
7.5%
Head and Neck
54.8%
52.2%
56.6%
48.7%
38.5%
66.6%
50.4%
Lower GI
12.4%
11.8%
12.6%
11.6%
8.5%
13.3%
13.0%
Upper GI
17.7%
16.6%
17.9%
16.2%
11.4%
12.1%
25.3%
HPB
2.3%
2.9%
2.2%
2.3%
1.1%
4.9%
3.9%
Trachea, Bronchus & Lung
26.8%
25.7%
27.1%
30.1%
17.6%
31.9%
21.7%
Melanoma
0.9%
1.2%
0.9%
0.4%
1.3%
2.0%
1.3%
Breast
35.1%
33.4%
36.0%
38.4%
14.0%
50.0%
28.6%
Cervix
39.6%
42.7%
38.1%
49.1%
29.3%
54.3%
42.6%
Other Female Genitals
14.3%
15.1%
14.1%
15.2%
14.0%
18.2%
13.8%
Prostate
17.1%
14.5%
18.5%
10.7%
5.8%
26.0%
11.3%
Kidney
5.2%
5.2%
5.2%
5.7%
4.4%
6.5%
4.2%
Bladder
15.4%
14.2%
15.9%
14.7%
11.6%
19.7%
9.1%
Brain and CNS
43.2%
43.9%
43.1%
42.2%
28.1%
54.7%
51.5%
Thyroid & other endocrine glands
29.7%
25.5%
31.8%
25.0%
18.4%
39.1%
13.1%
CUP
11.2%
9.9%
11.9%
8.2%
6.1%
12.9%
10.5%
Other invasive cancer
15.2%
12.3%
16.3%
12.5%
8.4%
13.5%
10.8%
Breast in situ
29.5%
30.7%
29.1%
38.6%
15.2%
38.0%
32.8%
Cervix in situ
0.0%
0.0%
0.0%
0.0%
0.0%
0.1%
0.1%
Other tumours
1.0%
1.1%
1.1%
0.4%
0.6%
2.9%
0.7%
Non-Melanoma Skin Cancer
1.0%
1.2%
1.1%
0.5%
1.7%
1.7%
0.9%
Printer-friendly version